SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Interim Management Statement

30 Jul 2014 07:00

RNS Number : 6728N
Victrex PLC
30 July 2014
 



 

 

 

 

30 July 2014

 

Victrex plc - Interim Management Statement

 

"Strong and broad based performance continues - trading in-line with expectations"

 

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its Interim Management Statement for the period 1 April 2014 to date.

 

Victrex continued its strong and broad based performance during the period. Third quarter Group sales volume, covering the period 1 April to 30 June, of 911 tonnes was 21% ahead of the prior year (Q3 2013: 756 tonnes), which reflects continued momentum in our core Victrex Polymer Solutions (VPS) business, good growth in Speciality Products and some new business in the Consumer Electronics market. Year to date sales volume of 2,495 tonnes was up 16% on the prior year (Q3 2013 YTD: 2,147 tonnes). In our Invibio medical business, Q3 revenue was 3% ahead of the prior year period, which saw the start of recovery in the Spine market.

 

Our Consumer Electronics opportunity, as highlighted at our interim results, will come through at a slightly softer margin than typical VPS business. As shorter lifecycle business, it will also be hedged at less favourable currency rates than the rest of the Group. Consumer Electronics has, historically, been one of the shorter lifecycle portions of the Group's portfolio, compared to our other longer lifecycle, high margin and high volume opportunities which we are focusing on. This opportunity, together with the current growth trends across core VPS and Speciality Products, keeps us well placed to continue our growth momentum through the rest of the second half and into 2015, with fourth quarter trading to date remaining positive across our business.

 

Looking forward, Sterling has continued to strengthen since our interim results in May and remains a considerable headwind for our next financial year. Our new capacity investment continues to be on track for commissioning in early 2015, to underpin core growth and new business opportunities and, despite our high capital expenditure programme, the Group's cash position remains strong. There have been no significant changes to the Company's financial position since our interim results announcement.

 

With our growth momentum remaining strong and a robust outlook across our markets, we continue to trade in line with market expectations.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

 

MHP Communications:

Nick Denton / James White +44 (0) 203 128 8600

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the Aerospace, Automotive, Electronics, Energy and Medical markets. Every day, millions of people rely on products or applications which contain our polymers, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

Investor and analyst call:

A call for investors and analysts will be held today, Wednesday 30 July at 09.00 UK time. For dial in details please contact James White at MHP Communications, james.white@mhpc.com or +44 (0) 203 128 8600

 

Next announcement:

Victrex will release its full year trading update on Thursday 9 October 2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEANXNAAELEFF
Date   Source Headline
30th Jun 20251:38 pmRNSTotal Voting Rights
30th Jun 20259:13 amRNSDirector Declaration
18th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jun 20251:56 pmRNSHolding(s) in Company
2nd Jun 202511:34 amRNSBlock listing Interim Review
2nd Jun 202510:25 amRNSHolding(s) in Company
30th May 20259:50 amRNSTotal Voting Rights
27th May 202512:40 pmRNSHolding(s) in Company
13th May 20253:30 pmRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSVictrex plc – Interim Results 2025
7th May 20257:00 amRNS‘Magma’ advances via TechnipFMC award
30th Apr 202511:00 amRNSTotal Voting Rights
31st Mar 20259:17 amRNSTotal Voting Rights
21st Mar 202510:34 amRNSDirector/PDMR Shareholding
28th Feb 20259:55 amRNSTotal Voting Rights
19th Feb 20259:00 amRNSAdditional Listing
7th Feb 20251:54 pmRNSResult of AGM
7th Feb 20257:00 amRNSAGM and Trading Update
31st Jan 20259:17 amRNSTotal Voting Rights
21st Jan 20251:56 pmRNSHolding(s) in Company
6th Jan 20251:00 pmRNSAnnual Financial Report
31st Dec 20249:00 amRNSTotal Voting Rights
16th Dec 20248:52 amRNSDirector/PDMR Shareholding
11th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 202411:46 amRNSDirector/PDMR Shareholding
10th Dec 20249:28 amRNSHolding(s) in Company
3rd Dec 202410:58 amRNSDirector/PDMR Shareholding
3rd Dec 20247:00 amRNSVictrex plc - Preliminary Results 2024
2nd Dec 20249:38 amRNSBlock listing Interim Review
29th Nov 20249:07 amRNSTotal Voting Rights
14th Nov 20249:31 amRNSHolding(s) in Company
31st Oct 202412:25 pmRNSTotal Voting Rights
14th Oct 20243:09 pmRNSHolding(s) in Company
30th Sep 20241:44 pmRNSTotal Voting Rights
27th Sep 20249:22 amRNSHolding(s) in Company
24th Sep 202411:24 amRNSDirector/PDMR Shareholding
17th Sep 20242:00 pmRNSUS FDA approval: Total Knee Study
12th Sep 202411:18 amRNSDirector/PDMR Shareholding
3rd Sep 20244:20 pmRNSHolding(s) in Company
30th Aug 20243:44 pmRNSDirector/PDMR Shareholding
30th Aug 20249:16 amRNSTotal Voting Rights
23rd Aug 20243:18 pmRNSHolding(s) in Company
9th Aug 202410:08 amRNSHolding(s) in Company
5th Aug 20241:56 pmRNSDirector/PDMR Shareholding
2nd Aug 202411:51 amRNSDirector/PDMR Shareholding
1st Aug 20241:20 pmRNSDirector/PDMR Shareholding
31st Jul 202412:20 pmRNSTotal Voting Rights
5th Jul 20242:02 pmRNSDirector/PDMR Shareholding
4th Jul 20247:00 amRNSQ3 Interim Management Statement
28th Jun 20249:52 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.